15th - 16th April 2021

MarketsandMarkets qPCR and dPCR Virtual Conference

12+
Speakers
100+
Attendees

Advancing qPCR and dPCR technological developments and its applications in oncology and infectious disease diagnostics

As per MarketsandMarkets research analysis, the global dPCR and qPCR is estimated to grow to USD 6,270.9 million by 2024 at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.

MarketsandMarkets are proud to host its inaugural “qPCR and dPCR Virtual Conference” which will be held on 15th - 16th April 2021. The conference will focus on the latest developments in digital and real time PCR and also, it’s application in cancer diagnosis and infectious disease diagnostics.

WHAT TO EXPECT
Key Highlights
  • New developments in qPCR and dPCR
  • Applications of qPCR and dPCR in cancer diagnosis and infectious diseases diagnostics
  • Data Analysis and Standardization
Who should attend?

From Universities and Pharma/Therapeutic Companies

Professors, Lecturers, Scientists, Researchers, Lab Heads, Managers, Directors working in-

  • qPCR
  • Digital PCR
  • NGS
  • Assay Development
  • Infectious Diseases
  • Microbiology
  • Oncology
  • Bioinformatics
  • Data Analysis
  • Genomics
  • Single Cell Analysis

 

CONFERENCE SPEAKERS
Speakers
David Zarling

David Zarling

CEO
Colby Pharmaceuticals, USA

David Zarling

CEO
Colby Pharmaceuticals, USA
 Loo Keat Wei

Loo Keat Wei

Assistant Professor, Faculty of Science
Universiti Tunku Abdul Rahman (UTAR), Malaysia

Loo Keat Wei

Assistant Professor, Faculty of Science
Universiti Tunku Abdul Rahman (UTAR), Malaysia
 Antoinette Perry

Antoinette Perry

Lecturer, Cancer Biology
University College Dublin, Ireland

Antoinette Perry

Lecturer, Cancer Biology
University College Dublin, Ireland
 Laxmi Silwal-Pandit

Laxmi Silwal-Pandit

Department of Cancer Genetics
Oslo University Hospital, Norway

Laxmi Silwal-Pandit

Department of Cancer Genetics
Oslo University Hospital, Norway
Valerie Taly

Valerie Taly

Research Director
CNRS, INSERM, France

Valerie Taly

Research Director
CNRS, INSERM, France
Andreas Weinhaeusel

Andreas Weinhaeusel

Thematic Coordinator, Molecular Diagnostics
AIT Austrian Institute of Technology, Austria

Andreas Weinhaeusel

Thematic Coordinator, Molecular Diagnostics
AIT Austrian Institute of Technology, Austria
Pawel Debski

Pawel Debski

Senior Analyst
Scope Fluidics, Poland

Pawel Debski

Senior Analyst
Scope Fluidics, Poland
PAST EVENT GALLERY